NCT03919448View on ClinicalTrials.gov

A Phase I Study Comparing Pharmacokinetics and Safety of Bevacizumab

PHASE1CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

September 11, 2019

Study Completion Date

September 11, 2019

Conditions
PharmacokineticsSafety Issues
Interventions
BIOLOGICAL

Bevacizumab

Single-dose infusion

Trial Locations (1)

C1425BAA

FP Clinical Pharma S.R.L., Buenos Aires

Sponsors

Collaborators (1)

Syngene
All Listed Sponsors
collaborator

FP Clinical Pharma S.R.L.

INDUSTRY

collaborator

Syngene

INDUSTRY

lead

Laboratorios Richmond S.A.C.I.F.

INDUSTRY